Semax is a synthetic peptide derived from a fragment of adrenocorticotropic hormone (ACTH) without retaining ACTH’s hormonal activity. Research has examined its influence on neurological and cognitive pathways.

Studies have investigated Semax in areas including learning, memory, neuroprotection, and responses to neurological injury. Its regulatory status and clinical availability vary considerably by country.

Evidence from experimental and regional clinical research should not be interpreted as equivalent to broad approval for nootropic or neuroprotective treatment. Product-specific formulation and intended use should be verified separately.